CD274 and neoplasm: In one report of 100 patients, fifty patients (50.0%) were PD-L1 negative, 34 patients (34.0%) were PD-L1 low expression (tumor proportion score [TPS] 1–50%), and 16 patients (16.0%) had a strong PD-L1 expression (TPS ≥ 50%) (30).